GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sanofi ADR SNY · USD

Health Care · US listing · 🇺🇸 United States

Compare

48.12

+2.30%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$53.91bn

FY2016FY2025

Net income

$9.02bn

FY2016FY2025

Free cash flow

$11.71bn

FY2016FY2025

Shareholders' equity

$82.37bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$53.91bn$51.11bn$48.03bn$46.81bn$45.21bn$43.13bn$43.43bn$41.17bn$41.80bn$40.04bn
Gross profit$38.86bn$35.87bn$33.46bn$33.10bn$31.07bn$29.09bn$29.60bn$27.98bn$28.40bn$27.69bn
Research and development$9.05bn$8.53bn$7.51bn$7.50bn$6.57bn$6.38bn$6.95bn$6.80bn$6.32bn$5.97bn
Operating income$11.08bn$8.37bn$8.03bn$12.00bn$9.38bn$16.40bn$3.52bn$5.66bn$6.70bn$7.54bn
Net income$9.02bn$6.42bn$6.23bn$9.66bn$7.18bn$14.19bn$3.18bn$4.97bn$9.71bn$5.43bn
Diluted earnings per share3.692.562.493.852.865.661.271.993.882.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$146.35bn$153.26bn$145.95bn$146.25bn$138.77bn$132.04bn$129.99bn$128.58bn$115.19bn$120.80bn
Cash and short-term investments$9.77bn$9.15bn$10.05bn$14.70bn$11.65bn$16.06bn$11.37bn$8.22bn$11.90bn$11.98bn
Total liabilities$63.59bn$63.41bn$60.14bn$59.52bn$59.10bn$59.04bn$61.63bn$60.44bn$47.98bn$54.18bn
Debt$21.77bn$18.77bn$19.55bn$22.28bn$23.75bn$26.25bn$29.99bn$28.51bn$1.47bn$21.38bn
Shareholders' equity$82.37bn$89.45bn$85.45bn$86.31bn$79.26bn$72.83bn$68.36bn$68.13bn$67.02bn$66.42bn
Shares outstanding2,441m2,507m2,507m2,508m2,510m2,507m2,506m2,491m2,506m2,566m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$14.00bn$10.48bn$11.84bn$12.15bn$12.14bn$8.56bn$8.90bn$6.40bn$8.52bn$9.05bn
Capital spending−$2.29bn−$3.69bn−$1.87bn−$2.54bn−$2.36bn−$2.40bn−$2.06bn−$2.28bn−$2.26bn−$2.40bn
Free cash flow$11.71bn$6.79bn$9.97bn$9.61bn$9.79bn$6.16bn$6.84bn$4.12bn$6.26bn$6.64bn
Dividends paid−$6.22bn−$5.43bn−$5.14bn−$4.81bn−$4.63bn−$4.54bn−$4.42bn−$4.35bn−$4.28bn−$4.34bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$14.20bn$12.98bn$14.09bn$15.20bn$12.39bn$12.24bn$8.81bn$16.34bn
Gross profit$10.71bn$9.36bn$9.90bn$11.26bn$8.94bn$8.91bn$6.19bn$11.62bn
Operating income$1.30bn$2.62bn−$1.20bn$4.18bn$1.70bn$2.58bn$661.3m$4.20bn
Net income$395.9m$1.86bn−$924.4m$3.23bn$4.55bn$2.16bn$575.9m$3.25bn
Diluted earnings per share0.170.78-0.381.321.860.890.231.30
Cash from operations$5.46bn$1.94bn$3.98bn$4.33bn$1.69bn$2.42bn—$4.44bn
Capital spending−$1.02bn—−$2.14bn−$975.0m————
Free cash flow$4.45bn—$1.83bn$3.35bn————
Total assets$148.95bn$147.75bn$146.35bn$149.79bn$144.21bn$152.22bn$153.26bn—
Cash and short-term investments$7.33bn$6.40bn$9.77bn$10.28bn$17.73bn$9.22bn$9.15bn$7.84bn
Debt$25.27bn$21.33bn$21.77bn$23.30bn$23.96bn$22.39bn$18.77bn—
Shareholders' equity$79.87bn$84.03bn$82.37bn$84.55bn$80.80bn$85.49bn$89.45bn$84.25bn

Financial ratios

Data as of 9 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin72.1%70.2%69.7%70.7%68.7%67.5%
Operating margin20.5%16.4%16.7%25.6%20.7%38.0%
Net margin16.7%12.6%13.0%20.6%15.9%32.9%
Return on equity10.9%7.2%7.3%11.2%9.1%19.5%
Return on assets6.2%4.2%4.3%6.6%5.2%10.7%
Free cash flow yield13.4%11.3%12.2%11.8%11.6%8.8%
Revenue growth5.5%6.4%2.6%3.5%4.8%-0.7%
Earnings growth40.5%3.0%-35.5%34.5%-49.4%346.4%
Current ratio1.09x1.46x1.27x1.42x1.44x1.75x
Debt to equity0.26x0.21x0.23x0.26x0.30x0.36x
Equity ratio56.3%58.4%58.5%59.0%57.1%55.2%
Interest coverage15.33x11.65x13.57x27.02x21.53x32.99x
R&D as a share of sales16.8%16.7%15.6%16.0%14.5%14.8%
Buybacks as a share of market value2.6%0.0%0.0%0.1%-0.1%-0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.8%4.6%3.0%
Operating income-2.6%-7.6%5.5%
Net income-2.3%-8.7%6.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin71.2%70.7%69.9%69.3%
Operating margin18.5%19.8%22.6%19.2%
Net margin14.7%15.7%18.3%16.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.118.820.012.617.58.639.621.811.119.1
Price to sales2.22.42.62.62.82.82.92.62.62.6

Market value over time

31 Oct 2016 to 8 Sept 2026, in USD

$100.22bn$103.28bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return2%-4%4%-4%4%-7%17%0%11%-8%

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 4 May 2026.

FY2026
Paid in the year2.422

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.